Back to Search
Start Over
Use of botulinum toxin for rosacea: a pilot study
- Source :
- Surgical & Cosmetic Dermatology, Vol 13 (2021)
- Publication Year :
- 2021
- Publisher :
- Sociedade Brasileira de Dermatologia (SBD), 2021.
-
Abstract
- Introduction: Rosacea is a chronic inflammatory skin disease. The intradermal application of botulinum toxin (BT) has been studied as a therapeutic option for patients who struggle to manage flushing and/or persistent facial erythema. There is no standard protocol for BT application in rosacea. Objective: To evaluate the effectiveness of botulinum toxin application on erythematotelan-giectatic rosacea. Methods: Pilot study with case series. We applied intradermal BT in 10 patients with a diagnosis of rosacea and symptoms of persistent erythema and/or facial flushing. Patients received 10 to 15 injections per hemiface (1 unit of onabotulinum BT per injection) and 0 to 5 injections in the nasal region, totaling 25 to 35 units per patient. Results: Seventy-five percent of the patients presented a reduction in flush and erythema intensity. The follow-up time was three months, and no serious adverse events were observed. Conclusions: The therapeutic arsenal to control erythema and facial flushing of rosacea, especially refractory to the usual treatment, should consider the intradermal application of BT type A.
- Subjects :
- erythema
rosacea
flushing
botulinum toxins
Dermatology
RL1-803
Subjects
Details
- Language :
- English, Portuguese
- ISSN :
- 19848773
- Volume :
- 13
- Database :
- Directory of Open Access Journals
- Journal :
- Surgical & Cosmetic Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.229f16532264188b05ff8c4e6680a37
- Document Type :
- article
- Full Text :
- https://doi.org/10.5935/scd1984-8773.2021130019